Yaofei Jiang1,2, Weixin Bei1, Wangzhong Li3

  • 1Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.

概括

免疫化疗在鼻癌 (NPC) 中重塑瘤微环境. 响应者表现出增强的CD8+T细胞活性,而非响应者则具有升高的免疫检查点基因,表明抵抗机制.